BACE1 and early-onset autosomal dominant Alzheimer disease: A recent case‐study further supporting the association of adaptive immunity and T‐cells in delayed DILI reactions is atabecestat (a BACE inhibitor developed for the treatment of Alzheimer's disease, but terminated due to liver enzyme elevations in some patients48).